IDEAYA Biosciences, Inc. (IDYA)
34.08
-1.26
(-3.57%)
USD |
NASDAQ |
Dec 09, 16:00
34.20
+0.12
(+0.35%)
Pre-Market: 09:18
IDEAYA Biosciences Shareholders Equity (Quarterly): 1.092B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 21.54B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| GT Biopharma, Inc. | 3.00M |
| Zymeworks, Inc. | 320.06M |
| Belite Bio, Inc. | 274.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.185B |
| Total Liabilities (Quarterly) | 93.10M |
| Debt to Equity Ratio | 0.0249 |
| Current Ratio | 12.44 |
| Net Debt Paydown Yield | -0.21% |